Actinium Pharmaceuticals reported $31.2M in Ordinary Share Capital for its fiscal quarter ending in September of 2025.





Ordinary Share Capital Change Date
AbbVie USD 1.77B 1.75B Jun/2025
Actinium Pharmaceuticals USD 31.2M 0 Sep/2025
Amgen USD 541M 1000K Jun/2026
Bioline Rx USD 2.61B 0 Dec/2025
Capricor Therapeutics USD 57.37M 11.65M Dec/2025
Pfizer USD 5.7B 0 Jun/2026